Cardiac Arrhythmia Monitoring Device Market Report: Trends, Forecast and Competitive Analysis to 2030

Cardiac Arrhythmia Monitoring Device Trends and Forecast

The future of the global cardiac arrhythmia monitoring device market looks promising with opportunities in the hospital & clinic and diagnostic center markets. The global cardiac arrhythmia monitoring device market is expected to reach an estimated $11.2 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are growing prevalence of cardiovascular diseases and rising awareness of the importance of early detection and treatment of cardiac arrhythmias.

A more than 150-page report is developed to help in your business decisions.

Cardiac Arrhythmia Monitoring Device by Segment

The study includes a forecast for the global cardiac arrhythmia monitoring device by type, application, end use, and region.

Cardiac Arrhythmia Monitoring Device Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• ECG Monitors
• Implantable Monitors
• Holter Monitors
• Mobile Cardiac Telematory
• Others

Cardiac Arrhythmia Monitoring Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Tachycardiac
• Atrial Tachycardiac
• Ventricular Tachycardiac
• Bradycardiac
• Premature Contraction

Cardiac Arrhythmia Monitoring Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Diagnostic Centers
• Others

Cardiac Arrhythmia Monitoring Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Cardiac Arrhythmia Monitoring Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cardiac arrhythmia monitoring device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cardiac arrhythmia monitoring device companies profiled in this report include-

• Abbott Laboratories
• GE Healthcare
• Koninklijke Philips
• Boston Scientific
• Medtronic
• Asahi Kasei
• Nihon Kohden

Cardiac Arrhythmia Monitoring Device Market Insights

Lucintel forecasts that holter monitor is expected to witness highest growth over the forecast period due to its various features, such as convenience, noninvasiveness, and accuracy.

Within this market, hospital and clinic will remain the largest segment due to growing demand for cardiac arrhythmia monitors in these facilities given to the availability of necessary infrastructure, medical knowledge, and resources needed.

North America is expected to witness highest growth over the forecast period due to growing risk of stroke among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Features of the Global Cardiac Arrhythmia Monitoring Device Market

Market Size Estimates: Cardiac arrhythmia monitoring device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cardiac arrhythmia monitoring device market size by various segments, such as by application, end use, and region in terms of value ($B).

Regional Analysis: Cardiac arrhythmia monitoring device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different applications, end uses, and regions for the cardiac arrhythmia monitoring device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cardiac arrhythmia monitoring device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cardiac arrhythmia monitoring device market size?

Answer: The global cardiac arrhythmia monitoring device market is expected to reach an estimated $11.2 billion by 2030.

Q.2 What is the growth forecast for cardiac arrhythmia monitoring device market?

Answer: The global cardiac arrhythmia monitoring device market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cardiac arrhythmia monitoring device market?

Answer: The major drivers for this market are growing prevalence of cardiovascular diseases and rising awareness of the importance of early detection and treatment of cardiac arrhythmias.

Q4. What are the major segments for cardiac arrhythmia monitoring device market?

Answer: The future of the cardiac arrhythmia monitoring device market looks promising with opportunities in the hospital & clinic and diagnostic center markets.

Q5. Who are the key cardiac arrhythmia monitoring device market companies?

Answer: Some of the key cardiac arrhythmia monitoring device companies are as follows:

• Abbott Laboratories
• GE Healthcare
• Koninklijke Philips
• Boston Scientific
• Medtronic
• Asahi Kasei
• Nihon Kohden

Q6. Which cardiac arrhythmia monitoring device market segment will be the largest in future?

Answer: Lucintel forecasts that holter monitor is expected to witness highest growth over the forecast period due to its various features, such as convenience, noninvasiveness, and accuracy.

Q7. In cardiac arrhythmia monitoring device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing risk of stroke among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cardiac arrhythmia monitoring device market by type (ecg monitors, implantable monitors, and holter monitors, mobile cardiac telematory, others), application (tachycardiac, atrial tachycardiac, ventricular tachycardiac, bradycardiac, and premature contraction), end use (hospitals & clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?